Physician profile
Mitchell Petit
NPI 1184628547
$1,668.05
in general payments reported to CMS, 2019-2025
19 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $116 · 2021: $12.66 · 2022: $420 · 2023: $352 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $268.61 | 2019-2020 | |
| Alcon Vision LLC | $166.49 | 2019-2023 | Eysuvis |
| Dompe US, INC. | $146.19 | 2025 | Oxervate |
| Allergan, INC. | $145.38 | 2019-2022 | |
| Amgen INC. | $141.06 | 2025 | Tepezza |
| New World Medical,INC. | $138.84 | 2023 | |
| Horizon Therapeutics Plc | $121.12 | 2023 | Tepezza |
| Abbvie INC. | $92.21 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $78.22 | 2022-2025 | Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $67.22 | 2019-2022 | |
| Optovue, INC. | $59.52 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $57.23 | 2019 | |
| Shire North American Group INC | $56.39 | 2019 | |
| Oyster Point Pharma, INC. | $33.36 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $24.07 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $23.28 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $20.02 | 2023 | Acthar |
| Eyevance Pharmaceuticals LLC | $16.18 | 2022 | |
| Sight Sciences, INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Petit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.